Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells

Leukemia

Volumn 14, Issue 7, 2000, Pages 1239-1246

  Bendall, L J ^a   Bradstock, K F ^a   Gottlieb, D J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

AML; CD34+ hematopoietic progenitors; CD44; Hematopoiesis; RT PCR

Indexed keywords

CD34 ANTIGEN; CD44V ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD; BONE MARROW; CHILD; CONTROLLED STUDY; EXON; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STEM CELL;

EID: 0033919668     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401830     Document Type: Article

References (48)

1. Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992; 103: 293-298.
2. Droll A, Dougherty S, Chiu R, Dirks J, McBride W, Cooper D, Dougherty G. Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 1995; 270: 11567-11573.
3. Elamin T, Smith L, Griffioen A, Schilder-Tol E, Borst J, Pals S. Signalling through CD44 is mediated by tyrosine kinases. J Biol Chem 1996; 271: 2863-2867.
4. Shimizu Y, van Seventer GA, Siraganian R, Wahl L, Shaw S. Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 1989; 143: 2457-2463.
5. Denning S, Le P, Singer K, Haynes B. Antibodies against the CD44p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 1990; 144: 7-15.
6. Ghaffari S, Dougherty G, Eaves A, Eaves C. Diverse effects of anti-CD44 antibodies on the stromal cell-mediated support of normal but not leukaemic (CML) haemopoiesis in vivo. Br J Haematol 1997; 97: 22-28.
7. Miyake K, Medina KL, Hayashi S-I, Ono S, Hamaoka T, Kincade PW. Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 1990; 171: 477-488.
8. Rossbach H-C, Krizanac-Bengez L, Santos E, GooleyT, Sandmaier B. An antibody to CD44 enhances hematopoiesis in long-term marrow cultures. Exp Hematol 1996; 24: 221-227.
9. Sandmaier B, Storb R, Appelbaum F, Gallatin W. An antibody that facilitates hematopoietic engraftment recognizes CD44. Blood 1990; 76: 630-635.
10. Screaton G, Bell M, Jackson D, Cornelis F, Gerth U, Bell J. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-12164.
11. Dougherty G, Landsorp P, Cooper D, Humpheries R. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte homing receptor expressed by hematopoietic cells. J Exp Med 1990; 174: 1-5.
12. Mackay C, Terpe H-J, Stauder R, Marston W, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994; 124: 71-82.
13. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257: 682-685.
14. Koopman G, Heider K, Horst E, Adolf G, van den Berg F, Ponta H, Herrlich P, Pals S. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.
15. Stauder R, Eisterer W, Thaler J, Gunthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995; 85: 2885-2899.
16. Stauder R, Van Driel M, Schwarzler C, Thaler J, Lokhorst H, Kreuser E, Bloem A, Gunthert U, Eisterer W. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 1996; 88: 3101-3108.
17. Kaufmann M, Heider K-H, Sinn H-P, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-619.
18. Heider K-H, Dämmrich J, Skroch-Angel P, Müller-Hermelink H-K, Vollmers H, Herrlich P, Ponta H. Differential expression of CD44 splice variants in intestinal-and diffuse-type human gastric carcinoma and normal gastric mucosa. Cancer Res 1993; 53: 4197-4203.
19. Terpe H-J, Koopmann R, Imhof B, Günthert U. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 1994; 174: 89-100.
20. Mulder J-W, Kruyt P, Sewnath M, Oosting J, Seldenrijk C, Weidema W, Offerhaus G, Pals S. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470-1472.
21. Tempfer C, Lösch A, Heinzel H, Häusler G, Hanzal E, Kölbl H, Breitenecker G, Kainz C. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 1996; 32A: 2023-2025.
22. Bartolazzi A, Jackson D, Bennett K, Aruffo A, Dirkinson R, Shields J, Whittie N, Stamenkovic I. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 1995; 108: 1723-1733.
23. Ghaffari S, Dougherty G, Lansdorp P, Eaves A, Eaves C. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 1995; 86: 2976-2985.
24. Legras S, Günthert U, Stauder R, Curt F, Oliferenko S, Kluin-Nelemans H, Marie P, Proctor S, Jasmin C, Smadja-Joffe F. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998; 91: 3401-3413.
25. Kortlepel K, Bendall LJ, Gottlieb DJ. Human acute myeloid leukemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia 1993; 7: 1174-1179.
26. + cells and acute myeloblastic but not lymphoblastic leukaemia cells to bone marrow stroma. Br J Haematol 1997; 98: 828-837.
27. Stamenkovic I, Amiot M, Pesando J, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989; 56: 1057-1062.
28. Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-5297.
29. Verfaillie CM. Direct contact between human primitive hemopoietic progenitors and bone marrow stroma is not required for long-term in vitro hemopoiesis. Blood 1992; 79: 2821-2826.
30. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, Wakeham A, Shahinian A, Catzavelos C, Rak J, Furlonger C, Zakarian A, Simard J, Ohashi P, Paige C, Gutierrez-Ramos J, Mak T. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997; 90: 2217-2233.
31. Khaldoyanidi S, Denzel A, Zöller M. Requirement for CD44 in proliferation and homing of hematopoietic precursor cells. J Leuk Biol 1996; 60: 579-592.
32. Sleeman J, Kondo K, Ponta H, Herrlich P. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J Biol Chem 1997; 272: 31837-31844.
33. Wielenga V, van der Voort R, Mulder J, Kruyt P, Weidema W, Oosting J, Seldenrijk C, van Krimpen C, Offerhaus G, Pals S. CD44 splice variants as prognostic markers in colorectal cancer. Scand J Gastroenterol 1998; 33: 82-87.
34. Khaldoyanidi S, Achtnich M, Hehlmann R, Zöller M. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression. Leukemia Res 1996; 20: 839-851.
35. Ghaffari S, Dougherty G, Eaves A, Eaves C. Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. Leukemia 1996; 10: 1773-1781.
36. Goodison S, Yoshida K, Sugino T, Woodman A, Gorham H, Bolodeoku J, Kaufmann M, Tarin D. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors. Cancer Res 1997; 57: 3140-3144.
37. Dall P, Heider K-H, Hekele A, von Minckwitz G, Kaufmann M, Ponta H, Herrlich P. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994; 54: 3337-3341.
38. Terpe H-J, Störkel S, Zimmer U, Anquez V, Fischer C, Pantel K, Günthert U. Expression of CD44 isoforms in renal cell tumors. Am J Pathol 1996; 148: 453-463.
39. Bolodeoku J, Yoshida K, Sugino T, Goodison S, Tarin D. Accumulation of immature intron-containing CD44 gene transcripts in breast cancer tissues. Mol Diagn 1996; 1: 175-181.
40. Stickeler E, Mobus V, Kieback D, Kohlberger P, Runnebaum I, Kreienberg R. Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer. Anticancer Res 1997; 17: 4395-4398.
41. Matsumura Y, Sugiyama M, Matsumura S, Hayle A, Robinson P, Smith J, Tarin D. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995; 177: 11-20.
42. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren B, Toge T, Tahara E, Tarin D. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res 1995; 55: 4273-4277.
43. Charrad R, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, Chomienne C, Smadja-Joffe F. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nature Med 1999; 5: 669-676.
44. Lackner C, Moser R, Bauernhofer T, Wilders-Trusching M, Samonigg H, Berghold A, Zatloukal K. Soluble CD44 v5 and v6 in serum of patients with breast canter. Correlation with expression of CD44 v5 and v6 variants in primary and location of distant metastasis. Breast Cancer Res Treat 1998; 47: 29-40.
45. Rall C, Rustgi A. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res 1995; 55: 1831-1835.
46. Yakushijin Y, Steckel J, Kharbanda S, Hasserjian R, Neuberg D, Jiang W, Shipp M. A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma. Blood 1998; 91: 4282-4291.
47. Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Cosio S, Prontera C, Bianchi R, Genazzani A. Serum assays of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer. Anticancer Res 1997; 17: 4463-4466.
48. Bahar R, Kunishi M, Kayada Y, Yoshiga K. CD44 variant v6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues. Int J Oral Max Surg 1997; 26: 443-446.